Oxygenta Pharmaceutical Ltd (524636) — Financial Results | 4 February 2026

· BSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

Oxygenta Pharmaceutical Ltd filed financial results for the period ending 2026-02-04. The filing presents performance metrics and financial position updates. Key metrics and operational details are available in the structured data. The company continues operations in the pharmaceutical sector with ongoing business activities reported through this regulatory submission.

📄 View Original Announcement (PDF)

📡 Get AI alerts when 524636 files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track 524636 — Free

📊 More 524636 filings

No other filings yet.

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts for your stocks — summarized by AI daily

Set up your AI Radar — pick stocks, get daily email summaries of new filings.

Set up AI Radar — Free

Free account · 2 AI queries/day